Endoluminal Sciences Company
Endoluminal Sciences develops novel platform technologies to enhance the clinical performance of endovascular prostheses.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Sydney, New South Wales, Australia
Founded Date:
2007
Employees Number:
11-50
Funding Status:
Seed
Estimated Revenue:
$10M to $50M
Register and Claim Ownership